Insights from field chemical immobilization of northern elephant seals over two decades
6 affiliations
- 1Department of Ecology and Evolutionary Biology, University of California Santa Cruz
- 2Institute of Marine Sciences, University of California Santa Cruz
- 3Moss Landing Marine Laboratories, San Jose State University
- 4Office of Research, University of California Santa Cruz
- 5ICF, Inc.
- 6Department of Biology, Sonoma State University
Abstract
Chemical immobilization is essential for ensuring the safety and welfare of wildlife and researchers during animal handling. We analyzed observation data from 1,464 immobilization procedures on 625 northern elephant seals (Mirounga angustirostris) conducted between 2004 and 2025 to describe our practices and insights. Inductions used tiletamine-zolazepam (Telazol®), with supplemental doses of ketamine, diazepam, and/or Telazol for augmentation (required to achieve satisfactory induction) and maintenance (required to maintain chemical immobilization for the procedure duration). Procedures spanned a wide range of body masses (57–668 kg) across the annual cycle (i.e., seasons) and life stages, including juveniles of both sexes and adult females up to 18 years old. For adult females, 68% received Telazol induction doses within ± 0.1 mg/kg of the 1.0 mg/kg target, indicating accurate mass estimation and a broad safety margin when paired with vigilant monitoring and respiratory support as needed. Lower induction doses were associated with a higher likelihood of augmentation drug administration, whereas higher doses were more often associated with faster-than-typical inductions and the administration of a respiratory stimulant. In procedures without augmentation or respiratory stimulant administration, smaller juveniles received higher mass-specific induction doses than adults across the observed body size range, regardless of sex. These findings show that age- and season-based mass estimates can refine dosing precision within a safe range. These findings describe recorded field decisions and procedural events (e.g., timing and sequence of drug administration) rather than direct physiological measurements of anesthetic depth or safety. Our long-term dataset provides empirically derived guidance to improve immobilization efficacy, safety, and consistency for elephant seals and related species.
Related
- Four decades of under-representation: a qualitative study to gain young adult insights to transform inclusive recruitment in clinical research
- Metabolic Profiling, Antioxidant Activity, and Mechanistic Insights of Chicory from Northern and Southern China: Integrating Metabolomics, Machine Learning, Molecular Docking, Molecular Dynamics Simulations, and In Vitro Assays
- Eco-Virological Patterns of Zoonotic Viruses in Neotropical Bats: Insights for Host Species Distributed in the Northern Andes—A Scoping Review and Trait-Based Analysis
- The Elephant in the Operating Room: Disclosure of Payments From Industry
- Hybrid pin penetration open stent technique: Retrospective study of a new approach to frozen elephant trunk procedure
BibTeX
@article{beltran2026insights,
title = {{Insights from field chemical immobilization of northern elephant seals over two decades}},
author = {Roxanne S. Beltran and A. Marm Kilpatrick and Arina B. Favilla and Patrick W. Robinson and Avalon Conklin and Rachel R. Holser and Garrett T. Shipway and Sarah H. Peterson and Birgitte I. McDonald and Megan E. Moriarty and Logan J. Pallin and Jason L. Hassrick and Cory D. Champagne and Z. E. A. Premo and Salma T. Abdel-Raheem and Daniel E. Crocker and Daniel P. Costa},
journal = {Scientific Reports},
year = {2026},
month = jul,
doi = {10.1038/s41598-026-61570-y},
url = {https://doi.org/10.1038/s41598-026-61570-y},
note = {CC BY},
}
RIS
TY - JOUR
TI - Insights from field chemical immobilization of northern elephant seals over two decades
AU - Roxanne S. Beltran
AU - A. Marm Kilpatrick
AU - Arina B. Favilla
AU - Patrick W. Robinson
AU - Avalon Conklin
AU - Rachel R. Holser
AU - Garrett T. Shipway
AU - Sarah H. Peterson
AU - Birgitte I. McDonald
AU - Megan E. Moriarty
AU - Logan J. Pallin
AU - Jason L. Hassrick
AU - Cory D. Champagne
AU - Z. E. A. Premo
AU - Salma T. Abdel-Raheem
AU - Daniel E. Crocker
AU - Daniel P. Costa
PY - 2026
DA - 2026/07/01
JO - Scientific Reports
DO - 10.1038/s41598-026-61570-y
UR - https://doi.org/10.1038/s41598-026-61570-y
AB - Chemical immobilization is essential for ensuring the safety and welfare of wildlife and researchers during animal handling. We analyzed observation data from 1,464 immobilization procedures on 625 northern elephant seals (Mirounga angustirostris) conducted between 2004 and 2025 to describe our practices and insights. Inductions used tiletamine-zolazepam (Telazol®), with supplemental doses of ketamine, diazepam, and/or Telazol for augmentation (required to achieve satisfactory induction) and maintenance (required to maintain chemical immobilization for the procedure duration). Procedures spanned a wide range of body masses (57–668 kg) across the annual cycle (i.e., seasons) and life stages, including juveniles of both sexes and adult females up to 18 years old. For adult females, 68% received Telazol induction doses within ± 0.1 mg/kg of the 1.0 mg/kg target, indicating accurate mass estimation and a broad safety margin when paired with vigilant monitoring and respiratory support as needed. Lower induction doses were associated with a higher likelihood of augmentation drug administration, whereas higher doses were more often associated with faster-than-typical inductions and the administration of a respiratory stimulant. In procedures without augmentation or respiratory stimulant administration, smaller juveniles received higher mass-specific induction doses than adults across the observed body size range, regardless of sex. These findings show that age- and season-based mass estimates can refine dosing precision within a safe range. These findings describe recorded field decisions and procedural events (e.g., timing and sequence of drug administration) rather than direct physiological measurements of anesthetic depth or safety. Our long-term dataset provides empirically derived guidance to improve immobilization efficacy, safety, and consistency for elephant seals and related species.
SN - 2045-2322
ER -